A recent meta-analysis looked at randomized clinical trials that examined the effect of thiazolidinediones on liver histology in patients with nonalcoholic steatohepatitis (NASH).
The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
Significant bleeding occurred in 2.5% of the patients on warfarin and 0.6% of the patients on non-vitamin K antagonist oral anticoagulants (NOACs).
ACP Gastroenterology Monthly is pleased to introduce its editorial advisory board.
What is the most likely cause of this 68-year-old man's ascites?
Six of the direct-acting antiviral (DAA) regimens yielded sustained virologic response rates above 95% in patients who had hepatitis C virus (HCV) genotype 1 without cirrhosis, including those with HIV co-infection.
The FDA suggests that clinicians should consider alternatives to eluxadoline in this population.
The drug reduces the frequency of diarrhea by inhibiting the production of serotonin by carcinoid tumors.